Normal immunoglobulin human 2.5g/25ml solution for infusion vials
Requires a prescription from a doctor or prescriber
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Yellow Card
Report side effects (MHRA)
Drug safety updates
MHRA alerts for Normal immunoglobulin human
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
3 branded products available
MHRA licensed products
View all licensed products for Normal immunoglobulin human on the MHRA register
Kiovig 2.5g/25ml solution for infusion vials
Privigen 2.5g/25ml solution for infusion vials
Normal immunoglobulin human 2.5g/25ml solution for infusion vials
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Guidelines from the National Institute for Health and Care Excellence
NICE clinical guidance(5)
Immunosuppressive therapy for kidney transplant in adults (TA481)
Coeliac disease (QS134)
Coeliac disease: recognition, assessment and management (NG20)
Fertility problems: assessment and treatment (NG257)
Imlifidase for desensitisation treatment before kidney transplant in people with chronic kidney disease (TA809)
Source: National Institute for Health and Care Excellence (NICE). Contains public sector information licensed under the Open Government Licence v3.0.
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 2 · 1965–2020
Showing the 50 most relevant studies, sorted by most relevant.
Jian Gao, Q. Zheng, Na Xin, et al.
Cancer Science, 2017
Michael A. Caligiuri
Blood, 2008
- Cytotoxicity, Immunologic
- Immunologic Surveillance
- Interferon-gamma
Allyson L. Byrd, Yasmine Belkaid, Julia A. Segre
Nature Reviews Microbiology, 2018
- Microbiota
- Bacteria
- Skin
Paulina Markowiak‐Kopeć, Katarzyna Śliżewska
Nutrients, 2017
- Gastrointestinal Microbiome
- Clinical Trials as Topic
- Diet
Ayuko Hoshino, Han Sang Kim, Linda Bojmar, et al.
Cell, 2020
- Extracellular Vesicles
- Machine Learning
- Cell Line
Giampaolo Merlini, Angela Dispenzieri, Vaishali Sanchorawala, et al.
Nature Reviews Disease Primers, 2018
- Immunoglobulin Light-chain Amyloidosis
- Angiotensin-Converting Enzyme Inhibitors
- Anti-Bacterial Agents
Haoyu Sun, Qiang Huang, Meijuan Huang, et al.
Hepatology, 2019
Michael S. Khodadoust, Niclas Olsson, Lisa E. Wagar, et al.
Nature, 2017
- Antigens, Neoplasm
- Cytotoxicity, Immunologic
- DNA Mutational Analysis
Hongde Hu, Fenglian Ma, Xin Wei, et al.
European Heart Journal, 2020
- SARS-CoV-2
- COVID-19
- Glucocorticoids
Jacques M. Lemire, John S. Adams, Rebecca Sakai, et al.
Journal of Clinical Investigation, 1984
- Mitogens
- Calcitriol
- Cell Division
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.